Inspirata Introduces a Strategic Advisory Board that Includes Leading Pathologists, Informaticists, Big Data Experts and Researchers in Digital Pathology
Tampa, FL (PRWEB) March 20, 2015 -- Inspirata, Inc. today announced its 13-member Strategic Advisory Board (SAB), which includes some of the top thought leaders in the field of digital pathology. The SAB comprises individuals who represent various clinical specialties, including pathology and oncology, as well as translational scientific research, computer vision and big data solutions.
The Chair of Inspirata’s SAB is Dr. Ulysses Balis, who is Professor of Pathology and Director of the Division of Pathology Informatics at the University of Michigan’s Department of Pathology. Dr. Balis specializes in improvements in the clinical pathology laboratory, including automation and real-time specimen tracking, whole-slide microscopy and telepathology and digital imaging solutions for surgical pathology.
According to Dr. Balis, “I am proud to Chair this outstanding assemblage of world-renowned scientists and inventors who are among the most-recognized thought leaders in precision medicine in general and cancer diagnostics in particular. My affiliation with Inspirata provides the unique opportunity for an amazing partnership of academia and industry to translate mature and proven diagnostic technologies and workflows from the bench to actual diagnosis and care of the oncology patient, in a highly expedited and optimized fashion.”
“The distinguished members of Inspirata’s Strategic Advisory Board were meticulously vetted and hand-selected because of their unrivaled expertise in their respective disciplines,” says Satish Sanan, Chairman and CEO of Inspirata. “These individuals have been and are continuing to play a critical roles in helping us clearly define and execute our mission of developing and delivering cancer diagnostic solutions that will revolutionize how pathologists work and contribute to precision medicine.”
About Inspirata, Inc.
Inspirata, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution as a service” delivery model. This comprehensive solution includes workflow automation and computer-aided cancer detection and diagnostic tools as supplemental aids to assist pathologists with diagnoses and to aid in the prediction of disease progression and therapeutic responses. For more information, please visit http://www.inspirata.com or contact [email protected].
Marjorie Bulone, Inspirata, Inc., http://www.inspirata.com, +1 813-570-8905, [email protected]
Share this article